Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAS2R4 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | DENND3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | GDF2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | VSIG4 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | SLC39A3 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | CARD8 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-06 |
mRNA | SEC23B | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | CFP | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | MRC2 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | ZNF804B | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |